IBDEI0I7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7935,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,7936,0)
 ;;=L20.84^^65^513^4
 ;;^UTILITY(U,$J,358.3,7936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7936,1,3,0)
 ;;=3^Eczema,Intrinsic
 ;;^UTILITY(U,$J,358.3,7936,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,7936,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,7937,0)
 ;;=L51.8^^65^513^11
 ;;^UTILITY(U,$J,358.3,7937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7937,1,3,0)
 ;;=3^Erythema Multiforme,Other
 ;;^UTILITY(U,$J,358.3,7937,1,4,0)
 ;;=4^L51.8
 ;;^UTILITY(U,$J,358.3,7937,2)
 ;;=^336639
 ;;^UTILITY(U,$J,358.3,7938,0)
 ;;=R23.4^^65^513^15
 ;;^UTILITY(U,$J,358.3,7938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7938,1,3,0)
 ;;=3^Eschar/Desquamination of Skin
 ;;^UTILITY(U,$J,358.3,7938,1,4,0)
 ;;=4^R23.4
 ;;^UTILITY(U,$J,358.3,7938,2)
 ;;=^5019296
 ;;^UTILITY(U,$J,358.3,7939,0)
 ;;=L49.9^^65^513^25
 ;;^UTILITY(U,$J,358.3,7939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7939,1,3,0)
 ;;=3^Exfoliation d/t Erythematous Cond w/ 90% or More Body Surface
 ;;^UTILITY(U,$J,358.3,7939,1,4,0)
 ;;=4^L49.9
 ;;^UTILITY(U,$J,358.3,7939,2)
 ;;=^5009199
 ;;^UTILITY(U,$J,358.3,7940,0)
 ;;=L74.9^^65^513^1
 ;;^UTILITY(U,$J,358.3,7940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7940,1,3,0)
 ;;=3^Eccrine Sweat Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,7940,1,4,0)
 ;;=4^L74.9
 ;;^UTILITY(U,$J,358.3,7940,2)
 ;;=^5009296
 ;;^UTILITY(U,$J,358.3,7941,0)
 ;;=L98.7^^65^513^16
 ;;^UTILITY(U,$J,358.3,7941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7941,1,3,0)
 ;;=3^Excessive/Redundant Skin/Subq Tissue
 ;;^UTILITY(U,$J,358.3,7941,1,4,0)
 ;;=4^L98.7
 ;;^UTILITY(U,$J,358.3,7941,2)
 ;;=^5138778
 ;;^UTILITY(U,$J,358.3,7942,0)
 ;;=L72.0^^65^513^7
 ;;^UTILITY(U,$J,358.3,7942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7942,1,3,0)
 ;;=3^Epidermal/Epidermoid Cyst
 ;;^UTILITY(U,$J,358.3,7942,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,7942,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,7943,0)
 ;;=L92.3^^65^514^1
 ;;^UTILITY(U,$J,358.3,7943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7943,1,3,0)
 ;;=3^FB Granuloma Skin/Subcutaneous Tissue
 ;;^UTILITY(U,$J,358.3,7943,1,4,0)
 ;;=4^L92.3
 ;;^UTILITY(U,$J,358.3,7943,2)
 ;;=^5009464
 ;;^UTILITY(U,$J,358.3,7944,0)
 ;;=L66.2^^65^514^4
 ;;^UTILITY(U,$J,358.3,7944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7944,1,3,0)
 ;;=3^Folliculitis Decalvans
 ;;^UTILITY(U,$J,358.3,7944,1,4,0)
 ;;=4^L66.2
 ;;^UTILITY(U,$J,358.3,7944,2)
 ;;=^5009254
 ;;^UTILITY(U,$J,358.3,7945,0)
 ;;=L73.9^^65^514^3
 ;;^UTILITY(U,$J,358.3,7945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7945,1,3,0)
 ;;=3^Follicular Disorder,Superficial
 ;;^UTILITY(U,$J,358.3,7945,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,7945,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,7946,0)
 ;;=L02.221^^65^514^5
 ;;^UTILITY(U,$J,358.3,7946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7946,1,3,0)
 ;;=3^Furuncle,Abdominal Wall
 ;;^UTILITY(U,$J,358.3,7946,1,4,0)
 ;;=4^L02.221
 ;;^UTILITY(U,$J,358.3,7946,2)
 ;;=^5008957
 ;;^UTILITY(U,$J,358.3,7947,0)
 ;;=L02.222^^65^514^6
 ;;^UTILITY(U,$J,358.3,7947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7947,1,3,0)
 ;;=3^Furuncle,Back
 ;;^UTILITY(U,$J,358.3,7947,1,4,0)
 ;;=4^L02.222
 ;;^UTILITY(U,$J,358.3,7947,2)
 ;;=^5008958
 ;;^UTILITY(U,$J,358.3,7948,0)
 ;;=L02.223^^65^514^7
 ;;^UTILITY(U,$J,358.3,7948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7948,1,3,0)
 ;;=3^Furuncle,Chest Wall
